← all works
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- Clinical Microbiology and Infection
- Topic
- Antifungal resistance and susceptibility
- Field
- Medicine
- Canadian institutions
- McGill UniversityInstitute of Infection and Immunity
- Funders
- Medical Research CouncilCentre Hospitalier Universitaire VaudoisAmplyxActelion PharmaceuticalsEuropean Society of Clinical Microbiology and Infectious DiseasesCidara TherapeuticsWellcome TrustDuke University
- Keywords
- PosaconazoleMedicineVoriconazoleGuidelineIntensive care medicineBronchoalveolar lavageAspergillosisCaspofunginInternal medicinePathologyImmunologyDermatologyAntifungalLung
- Has abstract in OpenAlex
- no